25Serious

Michael O'Connor

Ask VT AI

View News Summary

Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a promising platform for delivering RNA therapeutics to muscle tissue.
Tari Eason's contract uncertainty looms over the Houston Rockets' season, while the Astros face challenges and the Thunder and Lakers navigate their own narratives.
FIA investigates near-miss between marshals and Liam Lawson at Mexico City Grand Prix, raising concerns about safety protocols.

20 hours

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Ask VT AI

View News Summary

Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a promising platform for delivering RNA therapeutics to muscle tissue.
Tari Eason's contract uncertainty looms over the Houston Rockets' season, while the Astros face challenges and the Thunder and Lakers navigate their own narratives.
FIA investigates near-miss between marshals and Liam Lawson at Mexico City Grand Prix, raising concerns about safety protocols.

20 hours

United States Politics

Discover the latest news, candidates,  and key topics of US politics

Most Reported By
News from Michael O'Connor